Circulating RNA coding genes regulating apoptosis in maternal blood in severe early onset fetal growth restriction and pre-eclampsia

Journal of Perinatology

Volumn 33, Issue 8, 2013, Pages 600-604

  Whitehead, C L ^a   Walker, S P ^a   Lappas, M ^a   Tong, S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

apoptosis; biomarker; fetal growth restriction; Free RNA; placenta; pre eclampsia

Indexed keywords

BIM PROTEIN; BIOLOGICAL MARKER; CIRCULATING RNA; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; RNA; SURVIVIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BAD GENE; BCL XL GENE; BIM GENE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PROTEIN EXPRESSION; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVIN GENE; UMBILICAL ARTERY; UPREGULATION;

ADULT; APOPTOSIS; BIOLOGICAL MARKERS; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 84881160135     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2013.16     Document Type: Article

References (27)

1. Smith GC, Fretts RC. Stillbirth. Lancet 2007; 370(9600): 1715-1725
2. Froen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 2004; 83(9): 801-807
3. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet 2006; 367(9516): 1066-1074
4. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The ''Great Obstetrical Syndromes'' are associated with disorders of deep placentation. Am J Obstet Gynecol 2011; 204(3): 193-201
5. Sharp AN, Heazell AE, Crocker IP, Mor G. Placental apoptosis in health and disease. Am J Reprod Immunol 2010; 64(3): 159-169
6. Marsal K. Obstetric management of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009; 23(6): 857-870
7. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376(9741): 631-644
8. Backe B, Nakling J. Effectiveness of antenatal care: A population based study. Br J Obstet Gynaecol 1993; 100(8): 727-732
9. Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, Khong TY et al. Stillbirths: The way forward in high-income countries. Lancet 2011; 377(9778): 1703-1717
10. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350(9076): 485-487
11. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000; 46(11): 1832-1834
12. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008; 29(Suppl A): S73-S77
13. Hahn S, Huppertz B, Holgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: New tools to study abnormal placentation? Placenta 2005; 26(7): 515-526
14. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186(1): 158-166
15. Levy R, Smith SD, Yusuf K, Huettner PC, Kraus FT, Sadovsky Y et al. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 2002; 186(5): 1056-1061
16. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99(1): 159-167
17. Paiva P, Whitehead C, Saglam B, Palmer K, Tong S. Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia. J Clin Endocrinol Metab 2011; 96(11): E1807-E1815
18. Baschat AA. Fetal growth restriction-from observation to intervention. J Perinat Med 2010; 38(3): 239-246
19. Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977; 84(9): 656-663
20. Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997; 177(1): 57-65
21. Kumpel B, King MJ, Sooranna S, Jackson D, Eastlake J, Cheng R et al. Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta. Ann N Y Acad Sci 2008; 1137: 144-147
22. Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 2012; 59(2): 256-264
23. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset preeclampsia, but not normotensive intrauterine growth restriction. Placenta 2006; 27(1): 56-61
24. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000; 92(1): 35-43
25. Abumaree MH, Stone PR, Chamley LW. Changes in the expression of apoptosisrelated proteins in the life cycle of human villous trophoblast. Reprod Sci 2012; 19(6): 597-606
26. Rajakumar A, Chu T, Handley DE, Bunce KD, Burke B, Hubel CA et al. Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. Placenta 2011; 32(1): 70-78
27. Chen B, Longtine MS, Sadovsky Y, Nelson DM. Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts. Am J Physiol Cell Physiol 2010; 299(5): C968-C976